GAYATRI BIOORGANICS LTD. is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 | 0 | 0 | 0 |
| EBITDA (ex other income) | (0) | (1) | (1) | (0) | (1) |
| margin % | — | (46.1) | — | — | — |
| Owners' profit | (0) | (1) | (1) | (1) | (1) |
| EPS, as reported (₹) | (0.06) | (0.13) | (0.09) | 0.09 | 0.14 |
| ROE % · ROCE % | 1.5 · 1.6 | 2.9 · 2.4 | 1.9 · 1.7 | 2.0 · 1.4 | 3.0 · 42.5 |
| Debt / equity (x) | (1.05) | (1.03) | (1.03) | (1.03) | (1.00) |
| Cash from operations | (0) | (1) | (1) | (1) | (0) |
| Capex | 0 | 0 | 0 | 0 | 0 |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) |
| Net profit | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) |
| EPS (₹) | (0.03) | 0.02 | (0.02) | 0.02 | 0.03 | 0.03 | 0.03 | 0.05 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| DEEPAK FERTILIZERS & PETR | 16,727 | 17.0 | 2.24 | 12.2 | 9.9 | 8.4 | 14.6 | 26.1 |
| TATA CHEMICALS LTD | 15,683 | — | 0.71 | 141.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| GUJ NAR VAL FER & CHEM L | 8,273 | 8.0 | 0.91 | 6.0 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,773 | 55.4 | 18.15 | — | 18.8 | 24.3 | — | 16.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 1 Sept 2026 · 35th AGM on Sep 23; name change to Ananth BioOrganics proposed | board shareholder meetings | low | — | — |
| 1 Sept 2026 · Annual Report FY26: Loss Widens to Rs 111L, Zero Revenue, Name Change Proposed | results | high | — | — |
| 5 Aug 2026 · Chairman and Non-Executive Director resigns from board | management changes | high | — | — |
| 4 Aug 2026 · Management change, Q1 loss and negative networth at Gayatri BioOrganics | results | medium | — | — |
| 4 Aug 2026 · Q1 FY27 loss continues; chairman exits, MD elevated; name change proposed | results | high | — | — |
| 4 Aug 2026 · Q1 FY27 Results: Loss Narrows, Networth Deeply Negative, Going Concern Note | results | high | — | — |
| 30 Jul 2026 · Gayatri BioOrganics board meeting on 4 Aug 2026 for Q1 FY27 results | results | low | — | — |
| 11 Jul 2026 · Compliance certificate under SEBI DP Regulations filed for Q1 FY27 | compliance | minimal | — | — |
| 23 Jun 2026 · Trading window closed for Q1 FY27 results | compliance | minimal | — | — |
| 27 May 2026 · Annual Secretarial Compliance Report for the Year ended 31.03.2026 | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| GUJARAT ALKALIES & CHEM | 5,179 | 78.0 | 1.00 | 10.7 | (0.0) | 0.7 | 12.4 | 18.4 |
| GHCL LIMITED | 3,879 | 8.4 | 1.09 | 5.1 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,469 | 21.2 | 3.21 | 14.1 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,330 | 31.0 | 4.31 | 23.7 | 12.7 | 16.9 | — | 11.5 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 57.9 | 17.0 | 50 of 57 | 13% |
| ROCE | 62.7 | 6.2 | 1 of 65 | 100% |
| ROE | 3.0 | 4.9 | 39 of 65 | 41% |
| Debt / Equity | (1.0) | 0.2 | 3 of 65 | 97% |
| Profit growth | (140.8) | 21.0 | 58 of 64 | 10% |
| Market cap | 64 | 77 | 36 of 65 | 45% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
